Helicobacter pylori rescue treatment with vonoprazan, metronidazole, and sitafloxacin in the presence of penicillin allergy
Abstract Background and Aim To assess the efficacy and safety of 7‐day Helicobacter pylori rescue treatment consisting of a vonoprazan (VPZ), metronidazole (MNZ), and sitafloxacin (STFX) regimen (VPZ‐MNZ‐STFX therapy) in patients with penicillin allergy. Methods This was a registered prospective int...
Main Authors: | Soichiro Sue, Tomohiko Sasaki, Hiroaki Kaneko, Kuniyasu Irie, Masaaki Kondo, Shin Maeda |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-02-01
|
Series: | JGH Open |
Subjects: | |
Online Access: | https://doi.org/10.1002/jgh3.12492 |
Similar Items
-
Vonoprazan-Based Third-Line Therapy Has a Higher Eradication Rate against Sitafloxacin-Resistant Helicobacter pylori
by: Yoshimasa Saito, et al.
Published: (2019-01-01) -
Sitafloxacin for Third-Line <i>Helicobacter pylori</i> Eradication: A Systematic Review
by: Toshihiro Nishizawa, et al.
Published: (2021-06-01) -
Prospective Study of Vonoprazan-Based First-Line Triple Therapy with Amoxicillin and Metronidazole for Clarithromycin-Resistant <i>Helicobacter pylori</i>
by: Soichiro Sue, et al.
Published: (2023-08-01) -
Vonoprazan and high‐dose amoxicillin dual therapy for Helicobacter pylori first‐line eradication: A single‐arm, interventional study
by: Soichiro Sue, et al.
Published: (2023-01-01) -
Sitafloxacin Expresses Potent Anti-Mycobacterium abscessus Activity
by: Siyuan He, et al.
Published: (2022-01-01)